See also this year's filing and all EDGAR filings for this company.
PDF Report 0001900520_2026_Lomond_Therapeutics_Holdings_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001900520, Lomond Therapeutics Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 27,266,097 |
| 1 | AssetsNonCurrent | 0 |
| 2 | remainder_Assets | 3,553,577 |
| 3 | LiabilitiesCurrent | 9,508,490 |
| 4 | LiabilitiesNonCurrent | 0 |
| 5 | remainder_Liabilities | 0 |
| 6 | GeneralAndAdministrativeExpense | 4,200,525 |
| 7 | ProfessionalFees | 0 |
| 8 | remainder_Expenses | 20,258,461 |
| 9 | remainder_Revenues | 0 |
| 10 | remainder_NetIncome | 927,607 |
| 11 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 30,819,674 |
| 1 | Liabilities | 9,508,490 |
| 2 | Expenses | 24,458,986 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 21,311,184 |
| 5 | NetIncome | -23,531,379 |
| 6 | ComprehensiveNetIncome | -23,531,379 |
| 7 | BaseVar | 32,857,378 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.12 |
| 9 | EconomicCapitalRatio | 7.06 |
Edgar->Model Mapping
Feature Distribution
Change over Time
